Get Stock Quote Here Eleven Biotherapeutics (EBIO) designs and develops novel therapeutics for ocular diseases using its AMP-Rx™ protein engineering platform.
Response to Ted Depending on your risk tolerance, if you need to go long, $2 support could be your shot, but do not hang around if this loses $1.80. If you are comfortable with that kind of price moves, then give it a shot, but be careful, you can see how wildly this swings!
Late-stage clinical oncology company Eleven Biotherapeutics ($EBIO) is also likely to see early strength after reporting a significantly narrower fourth quarter loss.
Nice vol on Firday and holding up better than i expected today so far but not getting excited just yet. Hoping for some good news soon though because want to sell this bag, which seems to be taking forever
my bag just got even bigger lol >> Eleven Biotherapeutics Prices of $8.0 Million Underwritten Public Offering "...pricing of an underwritten public offering of 5,525,000 shares of its common stock, pre-funded warrants to purchase an aggregate of 4,475,000 shares of common stock, and common warrants to purchase up to an aggregate of 10,000,000 shares of common stock. Each share of common stock or pre-funded warrant, as applicable, is being sold together with a common warrant to purchase one share of common stock at a combined effective price to the public of $0.80 per share and accompanying common warrant..." https://finance.yahoo.com/news/eleven-biotherapeutics-prices-8-0-133400462.html
quite a few new SEC filings last couple days >> 13G filing - Form D filing + Phase 3 presentation next month - https://www.sec.gov/cgi-bin/browse-edgar?CIK=ebio&action=getcompany&owner=exclude
still have my little bag & actually might play this a little. ER fairly decent & results coming up & looks like company is doing some clean-up prep work via a name change etc Eleven Biotherapeutics Changes Name to Sesen Bio - http://www.sesenbio.com/
